DBVT
Price
$4.20
Change
+$0.02 (+0.48%)
Updated
Mar 10, 04:32 PM (EDT)
Capitalization
90.46M
NCNA
Price
$0.81
Change
-$0.08 (-8.99%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
3.16M
Ad is loading...

DBVT vs NCNA

Header iconDBVT vs NCNA Comparison
Open Charts DBVT vs NCNABanner chart's image
DBV Technologies S.A
Price$4.20
Change+$0.02 (+0.48%)
Volume$311
Capitalization90.46M
NuCana
Price$0.81
Change-$0.08 (-8.99%)
Volume$496
Capitalization3.16M
DBVT vs NCNA Comparison Chart
Loading...
DBVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DBVT vs. NCNA commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBVT is a Hold and NCNA is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (DBVT: $4.30 vs. NCNA: $0.91)
Brand notoriety: DBVT and NCNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DBVT: 16% vs. NCNA: 28%
Market capitalization -- DBVT: $90.46M vs. NCNA: $3.16M
DBVT [@Biotechnology] is valued at $90.46M. NCNA’s [@Biotechnology] market capitalization is $3.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DBVT’s FA Score shows that 0 FA rating(s) are green whileNCNA’s FA Score has 1 green FA rating(s).

  • DBVT’s FA Score: 0 green, 5 red.
  • NCNA’s FA Score: 1 green, 4 red.
According to our system of comparison, both DBVT and NCNA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DBVT’s TA Score shows that 4 TA indicator(s) are bullish while NCNA’s TA Score has 5 bullish TA indicator(s).

  • DBVT’s TA Score: 4 bullish, 1 bearish.
  • NCNA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, DBVT is a better buy in the short-term than NCNA.

Price Growth

DBVT (@Biotechnology) experienced а +4.88% price change this week, while NCNA (@Biotechnology) price change was -1.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

DBVT is expected to report earnings on Jul 29, 2024.

NCNA is expected to report earnings on Aug 14, 2024.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DBVT($90.5M) has a higher market cap than NCNA($3.16M). DBVT YTD gains are higher at: 39.159 vs. NCNA (-23.395). NCNA has higher annual earnings (EBITDA): -29.33M vs. DBVT (-96.59M). DBVT has more cash in the bank: 46.4M vs. NCNA (11.4M). NCNA has less debt than DBVT: NCNA (221K) vs DBVT (8.12M). DBVT (0) and NCNA (0) have equivalent revenues.
DBVTNCNADBVT / NCNA
Capitalization90.5M3.16M2,864%
EBITDA-96.59M-29.33M329%
Gain YTD39.159-23.395-167%
P/E RatioN/AN/A-
Revenue00-
Total Cash46.4M11.4M407%
Total Debt8.12M221K3,673%
FUNDAMENTALS RATINGS
DBVT vs NCNA: Fundamental Ratings
DBVT
NCNA
OUTLOOK RATING
1..100
187
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
16
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
7792
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NCNA's Valuation (16) in the Biotechnology industry is in the same range as DBVT (46). This means that NCNA’s stock grew similarly to DBVT’s over the last 12 months.

NCNA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as DBVT (100). This means that NCNA’s stock grew similarly to DBVT’s over the last 12 months.

NCNA's SMR Rating (100) in the Biotechnology industry is in the same range as DBVT (100). This means that NCNA’s stock grew similarly to DBVT’s over the last 12 months.

DBVT's Price Growth Rating (77) in the Biotechnology industry is in the same range as NCNA (92). This means that DBVT’s stock grew similarly to NCNA’s over the last 12 months.

DBVT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as NCNA (100). This means that DBVT’s stock grew similarly to NCNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DBVTNCNA
RSI
ODDS (%)
N/A
Bullish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
85%
Momentum
ODDS (%)
Bullish Trend 7 days ago
69%
Bearish Trend 7 days ago
78%
MACD
ODDS (%)
N/A
Bullish Trend 7 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
78%
Bearish Trend 7 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
75%
Bearish Trend 7 days ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 18 days ago
81%
Declines
ODDS (%)
Bearish Trend 14 days ago
89%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 7 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Ad is loading...
DBVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

DBVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, DBVT has been closely correlated with WINT. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if DBVT jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBVT
1D Price
Change %
DBVT100%
+8.59%
WINT - DBVT
78%
Closely correlated
-22.68%
NCNA - DBVT
77%
Closely correlated
N/A
CDTX - DBVT
77%
Closely correlated
+0.48%
SNPX - DBVT
75%
Closely correlated
+3.70%
RNAC - DBVT
74%
Closely correlated
+1.94%
More

NCNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NCNA has been closely correlated with CDTX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NCNA jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCNA
1D Price
Change %
NCNA100%
N/A
CDTX - NCNA
93%
Closely correlated
+0.48%
NBY - NCNA
92%
Closely correlated
+8.04%
WINT - NCNA
92%
Closely correlated
-22.68%
RNAC - NCNA
92%
Closely correlated
+1.94%
SNPX - NCNA
92%
Closely correlated
+3.70%
More